Highbridge Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-103,300	Closed	-$9.61M	–	1644
2017 Q3	$9.61M	Buy	103,300 +43,300	+72%	+$3.83M	0.14%	179
2017 Q2	$5.45M	Sell	60,000 -5,870	-9%	-$534K	0.08%	279
2017 Q1	$5.78M	Sell	65,870 -52,473	-44%	-$4.67M	0.08%	272
2016 Q4	$9.8M	Buy	118,343 +1,643	+1%	+$141K	0.17%	157
2016 Q3	$10.8M	Buy	116,700 +79,400	+213%	+$7.48M	0.17%	141
2016 Q2	$2.9M	Buy	+37,300	New	+$3.17M	0.05%	358
2015 Q4	–	Sell	-20,478	Closed	-$2.16M	–	1512
2015 Q3	$2.16M	Sell	20,478 -11,596	-36%	-$1.55M	0.03%	524
2015 Q2	$4.39M	Buy	32,074 +13,661	+74%	+$1.69M	0.06%	334
2015 Q1	$2.29M	Buy	+18,413	New	+$1.95M	0.03%	499
2013 Q4	–	Sell	-19,333	Closed	-$1.4M	–	1066
2013 Q3	$1.4M	Sell	19,333 -50,412	-72%	-$3.35M	0.01%	591
2013 Q2	$3.89M	Buy	+69,745	New	+$4.35M	0.04%	361